Podcast Summary: Clinical Trial Blazers – Interview with Michael Bailey, President and CEO of AVEO Oncology

Podcast Information:

• Title: The Great Detectives Present Dragnet (Old Time Radio)
• Host/Author: Adam Graham
• Episode: You Might Also Like: Clinical Trial Blazers
• Release Date: March 22, 2025

Note: While the episode is part of "The Great Detectives Present Dragnet" series, this particular segment features an insightful conversation from the "Clinical Trial Blazers" podcast, hosted by Alberto Grignolo, with guest Michael Bailey, President and CEO of AVEO Oncology.

Introduction

In the episode titled "You Might Also Like: Clinical Trial Blazers," host Alberto Grignolo engages in a comprehensive dialogue with Michael Bailey, the President and CEO of AVEO Oncology. The conversation delves into Bailey's extensive background in the biotech industry, his leadership philosophy, navigating the challenges of clinical trials, and his vision for the future of AVEO Oncology.

Background and Journey in Biotech

Michael Bailey's Career Path: Bailey begins by sharing his career trajectory, highlighting his transition from big pharma to biotech. Starting at SmithKline Beecham in London, he later moved to Genentech in Philadelphia, which marked his entrée into the biotech sector.

"One of the things about biotech that I think are hallmarks is the importance of bringing the customer into the development process earlier... more responsive and nimble, more innovation."
[01:13] – Michael Bailey

Motivation for Biotech: Bailey emphasizes the agility and innovative spirit of biotech companies compared to larger pharmaceutical firms. He appreciates the focus on patient-centric development and the dynamic environment that fosters rapid adaptation and creativity.

Becoming a CEO: Intentional or Serendipitous?

Path to Leadership: When asked about his journey to becoming a CEO, Bailey describes it as a blend of strategic opportunities and personal determination rather than a premeditated plan.

"I didn't set out to be a CEO, but in my career I always was very intrigued with the importance of strategic planning, clinical strategy, financial planning."
[03:07] – Michael Bailey

He underscores the importance of gaining diverse organizational insights and relying on a strong team to navigate the multifaceted responsibilities of a CEO.

Mentorship and Influences

Role Models and Mentors: Bailey attributes significant influence to mentors throughout his career, particularly highlighting Jerry Carabellas and Mike Bonnie.

"Jerry Carabellas really taught me to focus on the key driving factors... Mike Bonnie helped me with managing my board and the soft aspects of leadership."
[04:55] – Michael Bailey

He stresses the value of leadership coaching and the critical lesson of having the right team, emphasizing the importance of both bringing in the right people and making tough decisions to move out those who don't fit.

Leadership Style and Team Inspiration

Genuine Leadership: Describing himself as a genuine leader, Bailey avoids office politics and focuses on authenticity.

"I would say, in a word, genuine. I feel like I'm a genuine leader and that what you see is what you get."
[07:40] – Michael Bailey

Inspiring Teams: Rather than seeking to inspire directly, Bailey focuses on organizing a team united by a shared mission to improve patient lives. He believes in fostering a fun and positive work environment to maintain high morale.

"I've organized a team who's inspired by our mission to improve the lives of patients with cancer... I sincerely try to have fun along the way."
[07:49] – Michael Bailey

Superpowers and Personal Traits

Resilience and Optimism: Bailey identifies his ability to maintain optimism despite setbacks as his "superpower." This positive attitude helps cultivate a similar outlook within his team.

"My superpower is I don't dwell on the bad things that happen to me or the company... a positive attitude that tends to rub off on the people around you."
[09:07] – Michael Bailey

Navigating AVEO Oncology's Growth and Challenges

One Day at a Time: Bailey emphasizes a patient-focused approach, advocating for decisions that prioritize patient interests to provide clarity in challenging situations.

"Take it one day at a time. Always keep focused on the patient... what's in the best interest of the patient."
[10:03] – Michael Bailey

Clinical Trials and Product Development: He discusses AVEO Oncology's flagship product, TiVo (tivozenib), a VEGF receptor inhibitor approved in March 2021 for metastatic patients who have undergone prior systemic therapies. Bailey highlights TiVo's efficacy and tolerability as key strengths.

"TiVo is very effective as well as well tolerated, which is very important to patient experience."
[11:07] – Michael Bailey

Raising Capital and Financial Strategies

Capital Raising Essentials: Bailey outlines critical strategies for successful capital raising, including having a realistic plan, effective communication, maintaining credibility, and actively listening to investors.

"Pitching for capital is selling... credibility, integrity, transparency... Listening to investors."
[12:08] – Michael Bailey

He shares insights from his sales experience, likening capital raising to a sales call where honesty and responsiveness are paramount.

Cultural Integration Post-Acquisition

Navigating Cultural Differences: Following AVEO Oncology's acquisition by LG Chem in early 2023, Bailey discusses the importance of shared mission and vision in harmonizing differing corporate cultures.

"We share a common mission and vision... cultural sensitivity is crucial."
[14:11] – Michael Bailey

He elaborates on adapting to LG's cultural norms, emphasizing active listening and meticulous financial planning to align with their precise and polite working style.

Clinical Trial Strategies and Innovations

Blazing New Trails: Bailey advocates for innovative clinical trials targeting high unmet medical needs rather than conducting redundant "me too" studies. He highlights current projects addressing refractory patients in kidney cancer, head and neck cancer, and cancer cachexia.

"Blazing new trails is addressing high unmet medical needs... patients who are refractory to everything."
[16:44] – Michael Bailey

Risk Mitigation in Trials: He shares lessons learned from past trials, stressing the importance of listening to FDA feedback, understanding patient and competitive landscapes, designing studies to reduce risk, and carefully selecting patient populations to improve study outcomes.

"Listen very closely to the FDA... consider the customer, the patient, the competitive landscape."
[23:36] – Michael Bailey

Facing and Overcoming Challenges

Highs and Lows in Clinical Trials: Bailey recounts the emotional highs of successful Phase III trials, such as TiVo3, and the lows of trial failures, which impact capital access and company credibility. He underscores the necessity of perseverance balanced with strategic program termination when necessary.

"Any positive phase three is a super high... any phase three failures are super low."
[19:56] – Michael Bailey

Maintaining Motivation: Despite facing significant challenges, Bailey stays motivated by the mission to help patients and the personal fulfillment derived from leading impactful clinical trials.

"The patients really depend on it and we're doing something really important."
[28:36] – Michael Bailey

Future Excitements and Goals

Vision for AVEO Oncology: Looking ahead, Bailey is committed to establishing AVEO Oncology as a leading global oncology company. He expresses excitement about ongoing clinical trials, upcoming data readouts, and continued collaboration with advocacy groups to enhance patient care.

"I'm really excited about the clinical trials that we have ongoing and the readout of them."
[30:08] – Michael Bailey

He also highlights the anticipation surrounding trial outcomes, emphasizing the long-term rewards of bringing new therapies to patients.

Conclusion

The episode offers a deep dive into Michael Bailey's leadership and strategic approaches within the biotech industry. His emphasis on patient-centric development, innovative clinical trial design, and maintaining a positive organizational culture provides valuable insights for emerging biotech leaders and enthusiasts alike. Bailey's commitment to improving patient lives and navigating the complexities of clinical development underscores the pivotal role of leadership in advancing scientific innovation.

Notable Quotes:

• "Biotech sees the importance of bringing the customer into the development process earlier."
  [01:13] – Michael Bailey

• "What you see is what you get. I don't like politics."
  [07:49] – Michael Bailey

• "Don't dwell on the bad things... focus on the mission or the vision."
  [09:07] – Michael Bailey

• "Take it one day at a time. Always keep focused on the patient."
  [10:03] – Michael Bailey

• "Pitching for capital is selling... credibility, integrity, transparency."
  [12:08] – Michael Bailey

• "Listen very closely to the FDA... consider the customer, the patient, the competitive landscape."
  [23:36] – Michael Bailey

This detailed summary encapsulates the key discussions, insights, and conclusions from the interview with Michael Bailey on the "Clinical Trial Blazers" podcast. It provides a comprehensive overview for listeners who may not have had the chance to engage with the full episode.